Intellectual Property India Publishes Patent Application for 'Substituted Dihydrothienopyrimidine Compound, Preparation Method Therefor, And Use Thereof' Filed by Shanghai Yidi Biotechnology Co. Ltd.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202547094034 A) filed by Shanghai Yidi Biotechnology Co. Ltd., Shanghai, on Sept. 30, for 'substituted dihydrothienopyrimidine compound, preparation method therefor, and use thereof.'

Inventor(s) include Ye, Bin; and Yu, Jun.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a substituted dihydrothienopyrimidine compound, a preparation method therefor, and use thereof, and belongs to the field of biological medicines. Specifically, the present invention relates to a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition comprising the compound, and use thereof in the preparation of a drug for treating an inflammatory disease, an autoimmune disease, a metabolic disease, a nervous system disease, and related diseases, wherein the definition of each substituent in general formula (I) is the same as that in the specification."

The patent application was internationally filed on Apr. 12, 2024, under International application No.PCT/CN2024/087397.

Disclaimer: Curated by HT Syndication.